EVE EVE Investments Limited

—Mkt Cap: —P/E: —

EVE Health Group Limited, a life sciences and healthcare company, engages in the development and commercialization of pharmaceutical products in Australia. It operates in two segments, Meluka (Branded Wellness Consumer P…

Key Statistics

Company
Market Cap—
Enterprise Value2.80M USD
Revenue (TTM)796.89K USD
Gross Profit364.55K USD
Net Income (TTM)-1.31M USD
Revenue/Share0.0040 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorFinancial Services
IndustryCapital Markets
ISINAU000000EVE3
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-2.29
EV/Revenue3.51
P/S4.58
P/B1.36
EPS (TTM)-0.01
EPS (Forward)—
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin45.75%
Oper. Margin-201.63%
EBITDA Margin-153.28%
Profit Margin-163.97%
ROE-47.91%
ROA-44.21%
Growth
Revenue Growth-28.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.20M USD
CapEx (TTM)1.31K USD
FCF Margin-90.40%
FCF Yield—
Net Debt-855.69K USD
Net Debt/EBITDA0.70
Balance Sheet
Debt/Equity—
Current Ratio4.28
Quick Ratio3.94
Book Value/Sh0.01 AUD
Cash/Share0.0040 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:40
Split DateJun 2, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.352.33M
Float121.93M
Insiders57.34%
Institutions0.00%
Technical
SMA 500.0158 AUD
SMA 2000.0205 AUD
Beta0.40
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)217.35K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—